Allicin and L-carnitine as Preventive Agents Against Doxorubicin-induced Cardiac Damage in Rats ALC and LC protect against DOX induced cardiac toxicity
International Journal of Medical Toxicology and Forensic Medicine,
Vol. 14 No. 03 (2024),
6 August 2024
https://doi.org/10.32598/ijmtfm.v14i03.45510
Abstract
Background: Doxorubicin (DOX) is a potent anthracycline chemotherapy agent widely employed to treat various malignancies, such as cancers and this study sought to determine how allicin (ALC) and or L-carnitine (LC) affect DOX-induced cardiotoxicity in rats.
Methods: In this study, the possible alleviative role of ALC (20 mg/kg/day orally (PO)) or LC (100 mg/kg/day PO) or the combined treatment of both ALC and LC (with the previously mentioned dosages) was evaluated against the cardiotoxic effect of a widely used chemotherapeutic agent, DOX (20 mg DOX /kg intraperitoneal injection (IP) as a single dose) in rats in 30 days experiment.
Results: The results revealed that ALC and LC significantly suppressed the DOX-induced increment in serum levels of cardiac damage biomarkers, such as lactate dehydrogenase (LDH), creatine kinase (CK) and creatine kinase-megabyte (CK-MB). Moreover, DOX-associated oxidative stress, including the elevation in malondialdehyde (MDA) level and reduced activity of antioxidant enzymes, such as catalase (CAT) and superoxide dismutase (SOD) and the level of reduced glutathione (GSH) was corrected in ALC and or LC treated groups. Furthermore, DOX-induced cardiomyopathy showed significant pathological changes, including myocyte degeneration, vacuolization, interstitial edema, and focal necrosis. Nevertheless, the histopathological lesions were corrected in the treated groups mostly in the combined treatment with ALC plus LC. Compared to ALC and LC, ALC plus LC was more effective at restoring the cardiac injury biomarkers, inhibiting cardiac oxidative damage and preserving the cardiac architecture.
Conclusions: Conclusively, the study results evidenced the beneficial role of the combined treatment with ALC plus LC in mitigating DOX-induced cardiotoxicity.
- Doxorubicin (DOX)
- Cardiomyopathy
- Allicin (ALC)
- L-carnitine (LC)
- Oxidative damage
How to Cite
References
Fang Y, Yang W, Cheng L, Meng F, Zhang J, Zhong Z. EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo. Acta Biomaterialia. 2017; 64:323-33.[DOI:10.1016/j.actbio.2017.10.013] [PMID]
Tai P, Chen X, Jia G, Chen G, Gong L, Cheng Y, et al. WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis. Journal of translational Medicine. 2023; 21(1):823. [DOI:10.1186/s12967-023-04715-1] [PMID] [PMCID]
Pai VB, Nahata MC. Cardiotoxicity of chemotherapeutic agents: Incidence, treatment and prevention. Drug Safety. 2000; 22(4):263-302. [DOI:10.2165/00002018-200022040-00002] [PMID]
Wang Y, Chao X, Ahmad FUD, Shi H, Mehboob H, Hassan W. Phoenix dactylifera Protects against Doxorubicin-Induced Cardiotoxicity and Nephrotoxicity. Cardiology Research and Practice. 2019; 2019:7395239. [DOI:10.1155/2019/7395239] [PMID] [PMCID]
Abdel-Daim MM, Kilany OE, Khalifa HA, Ahmed AAM.Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis. Cancer Chemotherapy and Pharmacology. 2017; 80(4):745-53. [DOI:10.1007/s00280-017-3413-7] [PMID]
Wang ZY, Liu YY, Liu GH, Lu HB, Mao CY. l-Carnitine and heart disease. Life Sciences. 2018; 194:88-97. [DOI:10.1016/j.lfs.2017.12.015] [PMID]
Aboubakr M, Elsayd F, Soliman A, Fadl SE, El-Shafey A, Abdelhiee EY. L-Carnitine and vitamin E ameliorate cardiotoxicity induced by tilmicosin in rats. Environmental Science and Pollution Research International. 2020; 27(18):23026-34. [DOI:10.1007/s11356-020-08919-6] [PMID]
Mansour HH, El Kiki SM, Ibrahim AB, Omran MM. Effect of l-carnitine on cardiotoxicity and apoptosis induced by imatinib through PDGF/ PPARγ /MAPK pathways. Archives of Biochemistry and Biophysics. 2021; 704:108866. [DOI:10.1016/j.abb.2021.108866] [PMID]
Aboubakr M, Farag A, Elfadadny A, Alkafafy M, Soliman A, Elbadawy M. Antioxidant and anti-apoptotic potency of allicin and lycopene against methotrexate-induced cardiac injury in rats. Environmental Science and Pollution Research International. 2023; 30(38):88724-33. [DOI:10.1007/s11356-023-28686-4] [PMID]
Elkomy A, Abdelhiee EY, Fadl SE, Emam MA, Gad FA, Sallam A, et al. L-Carnitine mitigates oxidative stress and disorganization of cytoskeleton intermediate filaments in cisplatin-induced hepato-renal toxicity in rats. Frontiers in Pharmacology. 2020; 11:574441. [DOI:10.3389/fphar.2020.574441] [PMID] [PMCID]
AlAsmari AF, Ali N, Alharbi M, Alqahtani F, Alasmari F, Almoqbel D, et al. Geraniol ameliorates doxorubicin-mediated kidney injury through alteration of antioxidant status, inflammation, and apoptosis: Potential roles of NF-κB and Nrf2/Ho-1. Nutrients. 2022; 14(8):1620. [DOI:10.3390/nu14081620] [PMID] [PMCID]
Buhl SN, Jackson KY. Optimal conditions and comparison of lactate dehydrogenase catalysis of the lactate-to-pyruvate and pyruvate-to-lactate reactions in human serum at 25, 30, and 37 degrees C. Clinical Chemistry. 1978; 24(5):828-31. [DOI:10.1093/clinchem/24.5.828]
Neumeier D, Prellwitz W, Würzburg U, Brundobler M, Olbermann M, Just H-J, et al. Determination of creatine kinase isoenzyme MB activity in serum using immunological inhibition of creatine kinase M subunit activity. Activity kinetics and diagnostic significance in myocardial infarction. Clinica Chimica Acta; International Journal of Clinical Chemistry. 1976; 73(3):445-51. [DOI:10.1016/0009-8981(76)90146-7] [PMID]
Szasz G, Waldenström J, Gruber W. Creatine kinase in serum: 6. Inhibition by endogenous polyvalent cations, and effect of chelators on the activity and stability of some assay components. Clinical Chemistry. 1979; 25(3):446-52. [DOI:10.1093/clinchem/25.3.446] [PMID]
Aebi H. Catalase in vitro. Methods in Enzymology. 1984; 105:121-6. [DOI:10.1016/S0076-6879(84)05016-3] [PMID]
Habig WH, Pabst MJ, Jakoby WB. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. The Journal of Biological Chemistry. 1974; 249(22):7130-9. [DOI:10.1016/S0021-9258(19)42083-8] [PMID]
Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Analytical Biochemistry. 1978; 86(1):271-8. [DOI:10.1016/0003-2697(78)90342-1] [PMID]
Nishikimi M, Appaji N, Yagi K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochemical and Biophysical Research Communications. 1972; 46(2):849-54. [DOI:10.1016/S0006-291X(72)80218-3] [PMID]
Bancroft JD, Gamble M. Theory and Practice of Histological Techniques. Amsterdam: Elsevier Health Sciences; 2013.
Shivakumar P, Rani MU, Reddy AG, Anjaneyulu Y. A study on the toxic effects of Doxorubicin on the histology of certain organs.Toxicology International. 2012; 19(3):241-4. [DOI:10.4103/0971-6580.103656] [PMID] [PMCID]
Songbo M, Lang H, Xinyong C, Bin X, Ping Z, Liang S. Oxidative stress injury in doxorubicin-induced cardiotoxicity. Toxicology Letters. 2019; 307:41-8. [DOI:10.1016/j.toxlet.2019.02.013] [PMID]
Parker MA, King V, Howard KP: Nuclear magnetic resonance study of doxorubicin binding to cardiolipin containing magnetically oriented phospholipid bilayers. Biochimica et Biophysica Acta (BBA) - Biomembranes. 2001; 1514(2):206-16. [DOI:10.1016/S0005-2736(01)00371-6]
Khedr NF, El-Feky OA, Werida RH. L-carnitine mitigates trazadone induced rat cardiotoxicity mediated via modulation of autophagy and oxidative stress. Cardiovascular Toxicology. 2022; 22(9):831-41. [DOI:10.1007/s12012-022-09759-1] [PMID] [PMCID]
Fukai T, Folz RJ, Landmesser U, Harrison DG. Extracellular superoxide dismutase and cardiovascular disease. Cardiovascular Research. 2002; 55(2):239-49. [DOI:10.1016/S0008-6363(02)00328-0] [PMID]
Fattman CL, Schaefer LM, Oury TD. Extracellular superoxide dismutase in biology and medicine. Free Radical Biology & Medicine. 2003; 35(3):236-56. [DOI:10.1016/S0891-5849(03)00275-2] [PMID]
Fang YZ, Yang S, Wu G. Free radicals, antioxidants, and nutrition. Nutrition. 2002; 18(10):872-879. [DOI:10.1016/S0899-9007(02)00916-4] [PMID]
Xiong C, Wu YZ, Zhang Y, Wu ZX, Chen XY, Jiang P, et al. Protective effect of berberine on acute cardiomyopathy associated with doxorubicin treatment. Oncology Letters. 2018; 15(4):5721-9. [DOI:10.3892/ol.2018.8020]
Wei J, Yang Q, Lin L, Zhu C, Wei J. [Metformin mitigates doxorubicin-induced cardiotoxicity via the AMPK pathway (Chinese)]. Journal of Southern Medical University. 2023; 43(10):1682–8. [DOI:10.12122/j.issn.1673-4254.2023.10.05] [PMID]
Mustafa HN, Hegazy GA, Awdan SAE, AbdelBaset M. Protective role of CoQ10 or L-carnitine on the integrity of the myocardium in doxorubicin induced toxicity. Tissue & Cell. 2017; 49(3):410-26. [DOI:10.1016/j.tice.2017.03.007] [PMID]
Yalçin E, Oruç E, Cavuşoğlu K, Yapar K. Protective role of grape seed extract against doxorubicin-induced cardiotoxicity and genotoxicity in albino mice. Journal of Medicinal Food. 2010; 13(4):917-25. ]. [DOI:10.1089/jmf.2009.0162] [PMID]
Wang S, Kotamraju S, Konorev E, Kalivendi S, Joseph J, Kalyanaraman B. Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: The role of hydrogen peroxide. The Biochemical Journal. 2002; 367(Pt 3):729-40. [DOI:10.1042/bj20020752] [PMID] [PMCID]
Malone JI, Cuthbertson DD, Malone MA, Schocken DD. Cardio-protective effects of carnitine in streptozotocin-induced diabetic rats. Cardiovascular Diabetology. 2006; 5:2. [DOI:10.1186/1475-2840-5-2] [PMID] [PMCID]
- Abstract Viewed: 253 times
- pdf Downloaded: 212 times